- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.10. | Argenx walks away from Vyvgart Sjögren's disease trial after futility flag | ||
| 08.10. | Melissa explains it all in menopause team up with Bayer | ||
| 08.10. | Theramex pays up to $250M for Asieris' novel cervical lesion treatment | ||
| 07.10. | Novartis' Rhapsido tackles 2 most common forms of chronic hives with swift FDA expansion | ||
| 07.10. | Sanofi drafts New York Knicks star Karl-Anthony Towns for COVID, Nuvaxovid awareness push | ||
| 07.10. | Halozyme stymies subcutaneous Keytruda launch in select European countries as Merck vows to fight patent claims | ||
| 07.10. | How drugmakers are tapping into the GLP-1 frenzy's unprecedented 'consumer overlay' | ||
| 07.10. | New API Innovation Center index spotlights supply chain stress points | ||
| 07.10. | Catalent wins access to Iro and launches next-gen development platform | ||
| 07.10. | Scaling psychedelics comes with uncertainty 'baked into the sauce' | ||
| 07.10. | Rising Stars: How VML Health's Molly Kanofsky turns 'an idea on a page' into real-world impact | ||
| 07.10. | ViiV girds data package for Cabenuva in competitive HIV treatment market | ||
| 06.10. | AbbVie, Genmab score first-line DLBCL win for Epkinly, teeing up challenge to Roche's Polivy | ||
| 06.10. | BD commits $19B amid US onshoring push, with $3B earmarked for manufacturing growth | ||
| 05.10. | BridgeBio gears up for YouTube ATTR-CM awareness push | ||
| 05.10. | Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay | ||
| 05.10. | For biopharma manufacturing at speed and scale, the future is flexible | ||
| 05.10. | FDA dings Evolus for blurred lines between Botox rival, lipstick | ||
| 02.10. | Litfulo and tilrekimig data bolster Pfizer's immunology plans | ||
| 02.10. | Locking in on pharma's consumerization trend | ||
| 02.10. | The Oral GLP-1 Tracker: Foundayo surges as Wegovy pill stalls | ||
| 02.10. | Hiring for Resilience in Life Sciences Sales | ||
| 02.10. | Regulatory tracker: Camzyos wins pediatric nod at FDA | ||
| 02.10. | Teva, Samsung Bioepis deepen biosimilar bonds with new deal | ||
| 02.10. | AstraZeneca-Summit, Novo-Hengrui, Merck-Fierce Pharma Asia |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.